You are here: Welcome » Coalition for Epidemic Preparedness Innovations

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
coalition_for_epidemic_preparedness_innovations [2022/10/22 01:45]
liam [Portfolio] 		coalition_for_epidemic_preparedness_innovations [2024/03/14 01:56] (current)
liam [External links]
Line 116: Line 116:
  
 CEPI has also received support from private sector entities as well as public contributions through the [[United Nations Foundation]]'s [[COVID-19 Solidarity Response Fund]]. CEPI has also received support from private sector entities as well as public contributions through the [[United Nations Foundation]]'s [[COVID-19 Solidarity Response Fund]].
 +
 +As of July 2022, CEPI has received $2.3 billion USD from governments and $282.35 million from private investors, for a total of $2.6 billion. An additional $1.28 billion has been pledged for future donation.
 +
 +^  Private investors((//Investment Overview.// (2022). CEPI. https://web.archive.org/web/20220829190949/https://cepi.net/wp-content/uploads/2022/02/2022_07_06-CEPI-Investment-Overview.pdf))  ^^^
 +^ Name  ^ Contributions (USD)  ^ Pledges (USD)  ^
 +| [[Avast]]  | $8,000,000  | -  |
 +| [[Bill & Melinda Gates Foundation]]  | $121,400,000  | $154,000,000  |
 +| [[Fidelity]]  | $1,490,000  | -  |
 +| [[Goldman Sachs]]  | $1,630,000  | -  |
 +| [[Nestlé]]  | $1,040,000  | -  |
 +| [[Sumitomo Mitsui Banking Corporation]]  | $1,140,000  | -  |
 +| [[Paul G. Allen Family Foundation]]  | $3,500,000  | -  |
 +| [[COVID-19 Solidarity Response Fund]]  | $10,000,000  | -  |
 +| [[Wellcome Trust]]  | $130,900,000  | $150,000,000  |
 +| Others (less than $1 million)  | $3,240,000  | -  |
 ===== Activities ===== ===== Activities =====
  
Line 170: Line 185:
 | [[pharmaceutical_companies:IDT Biologika]]  | MERS coronavirus  | Up to $36 million USD  | Recombinant viral vector (preclinical)  | | [[pharmaceutical_companies:IDT Biologika]]  | MERS coronavirus  | Up to $36 million USD  | Recombinant viral vector (preclinical)  |
 | [[pharmaceutical_companies:Janssen]], [[University of Oxford]]  | Lassa virus  | Up to $19 million USD for Janssen's Lassa, MERS, Nipah vaccines  | Recombinant viral vector (preclinical)  | | [[pharmaceutical_companies:Janssen]], [[University of Oxford]]  | Lassa virus  | Up to $19 million USD for Janssen's Lassa, MERS, Nipah vaccines  | Recombinant viral vector (preclinical)  |
 +| Janssen, University of Oxford  | MERS coronavirus  | -  | Recombinant viral vector (preclinical)  |
 +| Janssen, University of Oxford  | Nipah virus  | -  | Recombinant viral vector (preclinical)  |
 +| [[Imperial College London]]  | [[Marburg virus]]  | Up to $8.4 million USD  | Nucleic acid (preclinical)  |
 ===== External links ===== ===== External links =====
  
   * [[https://en.wikipedia.org/wiki/Coalition_for_Epidemic_Preparedness_Innovations|Wikipedia]]   * [[https://en.wikipedia.org/wiki/Coalition_for_Epidemic_Preparedness_Innovations|Wikipedia]]
 +  * [[https://wiki.whiteroseintelligence.com/Coalition-for-Epidemic-Preparedness-Innovations|White Rose Wiki]]
   * [[https://wikispooks.com/wiki/Coalition_for_Epidemic_Preparedness_Innovations|Wikispooks]]   * [[https://wikispooks.com/wiki/Coalition_for_Epidemic_Preparedness_Innovations|Wikispooks]]
Back to top